Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-20-008051
Filing Date
2020-07-06
Accepted
2020-07-06 17:46:42
Documents
2
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1669
2 POWER OF ATTORNEY pakianathanpoa.txt EX-24 3396
  Complete submission text file 0001179110-20-008051.txt   6473
Mailing Address 160 BOVET ROAD, SUITE 408 C/O DELPHI VENTURES SAN MATEO CA 94402
Business Address
PAKIANATHAN DEEPIKA (Reporting) CIK: 0001270734 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 201014463

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations